Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deuterated Drugs Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Austedo
1.2.3 Zepsun
1.2.4 Others
1.3 Market by Application
1.3.1 Global Deuterated Drugs Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Huntington'S Disease (HD)
1.3.3 Tardive Dyskinesia (TD)
1.3.4 Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Deuterated Drugs Market Perspective (2018-2033)
2.2 Deuterated Drugs Growth Trends by Region
2.2.1 Global Deuterated Drugs Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Deuterated Drugs Historic Market Size by Region (2018-2023)
2.2.3 Deuterated Drugs Forecasted Market Size by Region (2024-2033)
2.3 Deuterated Drugs Market Dynamics
2.3.1 Deuterated Drugs Industry Trends
2.3.2 Deuterated Drugs Market Drivers
2.3.3 Deuterated Drugs Market Challenges
2.3.4 Deuterated Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Deuterated Drugs Players by Revenue
3.1.1 Global Top Deuterated Drugs Players by Revenue (2018-2023)
3.1.2 Global Deuterated Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Deuterated Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Deuterated Drugs Revenue
3.4 Global Deuterated Drugs Market Concentration Ratio
3.4.1 Global Deuterated Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deuterated Drugs Revenue in 2023
3.5 Deuterated Drugs Key Players Head office and Area Served
3.6 Key Players Deuterated Drugs Product Solution and Service
3.7 Date of Enter into Deuterated Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Deuterated Drugs Breakdown Data by Type
4.1 Global Deuterated Drugs Historic Market Size by Type (2018-2023)
4.2 Global Deuterated Drugs Forecasted Market Size by Type (2024-2033)
5 Deuterated Drugs Breakdown Data by Application
5.1 Global Deuterated Drugs Historic Market Size by Application (2018-2023)
5.2 Global Deuterated Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Deuterated Drugs Market Size (2018-2033)
6.2 North America Deuterated Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Deuterated Drugs Market Size by Country (2018-2023)
6.4 North America Deuterated Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Deuterated Drugs Market Size (2018-2033)
7.2 Europe Deuterated Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Deuterated Drugs Market Size by Country (2018-2023)
7.4 Europe Deuterated Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Deuterated Drugs Market Size (2018-2033)
8.2 Asia-Pacific Deuterated Drugs Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Deuterated Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Deuterated Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Deuterated Drugs Market Size (2018-2033)
9.2 Latin America Deuterated Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Deuterated Drugs Market Size by Country (2018-2023)
9.4 Latin America Deuterated Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Deuterated Drugs Market Size (2018-2033)
10.2 Middle East & Africa Deuterated Drugs Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Deuterated Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Deuterated Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Deuterated Drugs Introduction
11.1.4 Teva Revenue in Deuterated Drugs Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Introduction
11.2.4 Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.2.5 Suzhou Zelgen Biopharmaceuticals Recent Development
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Detail
11.3.2 Concert Pharmaceuticals Business Overview
11.3.3 Concert Pharmaceuticals Deuterated Drugs Introduction
11.3.4 Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.3.5 Concert Pharmaceuticals Recent Development
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Detail
11.4.2 Vertex Pharmaceuticals Business Overview
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Introduction
11.4.4 Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.4.5 Vertex Pharmaceuticals Recent Development
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Detail
11.5.2 Hinova Pharma Business Overview
11.5.3 Hinova Pharma Deuterated Drugs Introduction
11.5.4 Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023)
11.5.5 Hinova Pharma Recent Development
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Detail
11.6.2 Otsuka Pharmaceutical (Avanir) Business Overview
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Introduction
11.6.4 Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023)
11.6.5 Otsuka Pharmaceutical (Avanir) Recent Development
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Detail
11.7.2 Poxel SA (DeuteRx) Business Overview
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Introduction
11.7.4 Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023)
11.7.5 Poxel SA (DeuteRx) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Deuterated Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Austedo
Table 3. Key Players of Zepsun
Table 4. Key Players of Others
Table 5. Global Deuterated Drugs Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global Deuterated Drugs Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Deuterated Drugs Market Share by Region (2018-2023)
Table 9. Global Deuterated Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Deuterated Drugs Market Share by Region (2024-2033)
Table 11. Deuterated Drugs Market Trends
Table 12. Deuterated Drugs Market Drivers
Table 13. Deuterated Drugs Market Challenges
Table 14. Deuterated Drugs Market Restraints
Table 15. Global Deuterated Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Deuterated Drugs Market Share by Players (2018-2023)
Table 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)
Table 18. Ranking of Global Top Deuterated Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Deuterated Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Deuterated Drugs Product Solution and Service
Table 22. Date of Enter into Deuterated Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Deuterated Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Deuterated Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Deuterated Drugs Revenue Market Share by Type (2024-2033)
Table 28. Global Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Deuterated Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Deuterated Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Deuterated Drugs Revenue Market Share by Application (2024-2033)
Table 32. North America Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Deuterated Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. Europe Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Deuterated Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Deuterated Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 39. Asia-Pacific Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Deuterated Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 42. Latin America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Deuterated Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Middle East & Africa Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Deuterated Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Deuterated Drugs Product
Table 50. Teva Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 53. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 54. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product
Table 55. Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 56. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 57. Concert Pharmaceuticals Company Detail
Table 58. Concert Pharmaceuticals Business Overview
Table 59. Concert Pharmaceuticals Deuterated Drugs Product
Table 60. Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 61. Concert Pharmaceuticals Recent Development
Table 62. Vertex Pharmaceuticals Company Detail
Table 63. Vertex Pharmaceuticals Business Overview
Table 64. Vertex Pharmaceuticals Deuterated Drugs Product
Table 65. Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 66. Vertex Pharmaceuticals Recent Development
Table 67. Hinova Pharma Company Detail
Table 68. Hinova Pharma Business Overview
Table 69. Hinova Pharma Deuterated Drugs Product
Table 70. Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 71. Hinova Pharma Recent Development
Table 72. Otsuka Pharmaceutical (Avanir) Company Detail
Table 73. Otsuka Pharmaceutical (Avanir) Business Overview
Table 74. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product
Table 75. Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 76. Otsuka Pharmaceutical (Avanir) Recent Development
Table 77. Poxel SA (DeuteRx) Company Detail
Table 78. Poxel SA (DeuteRx) Business Overview
Table 79. Poxel SA (DeuteRx) Deuterated Drugs Product
Table 80. Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 81. Poxel SA (DeuteRx) Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deuterated Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Deuterated Drugs Market Share by Type: 2023 VS 2033
Figure 3. Austedo Features
Figure 4. Zepsun Features
Figure 5. Others Features
Figure 6. Global Deuterated Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Deuterated Drugs Market Share by Application: 2023 VS 2033
Figure 8. Huntington'S Disease (HD) Case Studies
Figure 9. Tardive Dyskinesia (TD) Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Deuterated Drugs Report Years Considered
Figure 13. Global Deuterated Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Deuterated Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 15. Global Deuterated Drugs Market Share by Region: 2023 VS 2033
Figure 16. Global Deuterated Drugs Market Share by Players in 2023
Figure 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Deuterated Drugs Revenue in 2023
Figure 19. North America Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Deuterated Drugs Market Share by Country (2018-2033)
Figure 21. United States Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Deuterated Drugs Market Share by Country (2018-2033)
Figure 25. Germany Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Deuterated Drugs Market Share by Region (2018-2033)
Figure 33. China Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Deuterated Drugs Market Share by Country (2018-2033)
Figure 41. Mexico Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Deuterated Drugs Market Share by Country (2018-2033)
Figure 45. Turkey Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Deuterated Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Teva Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 48. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 49. Concert Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 50. Vertex Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 51. Hinova Pharma Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 52. Otsuka Pharmaceutical (Avanir) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 53. Poxel SA (DeuteRx) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed